Amino Acid Sequence Of Octreotide (Image 01)
Octreotide Acetate Kit
Product Images NDC 67457-756
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 67457-756). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Octreotide Acetate Injection 10 mg/vial Carton Label (Image 02)
Octreotide Acetate Injection 20 mg/vial Carton Label (Image 03)
This text is from a packaging label for Octreotide Acetate, an injectable suspension intended for gluteal intramuscular use. The contents include a single-dose vial with Octreotide Acetate and a prefilled syringe with a diluent solution for reconstitution. It is produced by Mylan Institutional LLC in Morgantown, WV, USA. The product is for intragluteal injection.*
Octreotide Acetate Injection 30 mg/vial Carton Label (Image 04)
The text provided appears to be about a medication product called "Octreotide Acetate for Injectable Suspension" intended for intramuscular use. The description includes details about the single-dose vial, pre-filled syringe with a diluent solution, vial adapter, and safety injection needle. It mentions Mylan as the manufacturer. The product is specifically for intragluteal injection.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
